4/A//SEC Filing
LEE WILLIS C 4/A
Accession 0001209191-24-000442
CIK 0000822370other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:59 PM ET
Size
14.7 KB
Accession
0001209191-24-000442
Insider Transaction Report
Form 4/AAmended
LEE WILLIS C
DirectorVice Chairman & COO
Transactions
- Purchase
Common stock, $0.001 par value
2023-08-25$0.21/sh+6,500$1,365→ 37,100 total(indirect: By IRA) - Purchase
Common stock, $0.001 par value
2023-11-29$0.12/sh+36,000$4,320→ 335,724 total - Purchase
Common stock, $0.001 par value
2023-08-31$0.15/sh+6,000$900→ 43,100 total(indirect: By IRA) - Purchase
Common stock, $0.001 par value
2023-11-30$0.12/sh+59,400$7,128→ 395,124 total - Purchase
Common stock, $0.001 par value
2023-11-14$0.12/sh+1,100$132→ 44,200 total(indirect: By IRA) - Purchase
Common stock, $0.001 par value
2023-11-28$0.12/sh+12,000$1,440→ 299,724 total
Holdings
- 241,194(indirect: By IRA)
Common stock, $0.001 par value
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.12 to $0.13, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4.
- [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.11 to $0.13, inclusive.
Documents
Issuer
Emmaus Life Sciences, Inc.
CIK 0000822370
Entity typeother
Related Parties
1- filerCIK 0001517775
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:59 PM ET
- Size
- 14.7 KB